Chapter 9.25 - LIMITING THE SALE OF PSEUDOEPHEDRINE-CONTAINING PRODUCTS
Section:
9.25.010 Retail sale of methamphetamine precursor drugs – limitations.
9.25.010 Retail sale of methamphetamine precursor drugs – limitations.
A. Retail distributors selling products containing a methamphetamine precursor drug, defined here as ephedrine, pseudoephedrine, or phenylpropanolamine or their salts, isomers, or salts of isomers, must place such products in a secured area that is only accessible to the public with the assistance of the retailer or its employees, who shall be trained to prevent theft or diversion of these products. Such retailers must provide proof of such a training program to the City.
1) Methamphetamine precursor drug does not include a substance contained in any package or container that is labeled by the manufacturer as intended for pediatric use.
B. Retail distributors are prohibited from selling to a purchaser methamphetamine precursor drugs except in blister packs with each blister to contain not more than two dosage units, or when the use of blister packs is technically infeasible, sales in unit dose packets or pouches.
C. Retail distributors may not deliver in a single sale in or from a store more than three packages of a methamphetamine precursor drug or a combination of two or more methamphetamine precursor drugs.
D. Upon satisfactory application by a manufacturer, the City of Evans may exempt any product it determines to have been formulated to effectively prevent the conversion of any active ingredient in the product into methamphetamine or any other controlled substance.
E. No person in the course of selling, offering for sale, or otherwise distributing a PSE product shall provide locally displayed advertisement or representation in any manner that the product causes euphoria, ecstasy, a “buzz” or “high,” or an altered mental state; heightens sexual performance; or, because it contains ephedrine alkaloids, increased muscle mass. (Ord. 355-05)
